Bioethics Stock Today
| BOTH Stock | USD 0.01 0.00 0.00% |
PerformanceWeakest
| Odds Of DistressHigh
|
Bioethics is trading at 0.0051 as of the 26th of December 2025. This is a No Change since the beginning of the trading day. The stock's open price was 0.0051. Bioethics has more than 66 % chance of experiencing financial distress in the next few years of operation. It also generated negative returns for investors over the last 90 days. The performance scores are derived for the period starting the 26th of November 2025 and ending today, the 26th of December 2025. Click here to learn more.
It intends to seek, investigate, and if warranted acquire an interest in a business opportunity. The company was incorporated in 1990 and is based in Ogden, Utah. Bioethics is traded on OTC Exchange in the United States. The company has 1.14 M outstanding shares. More on Bioethics
Moving together with Bioethics Pink Sheet
Moving against Bioethics Pink Sheet
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Bioethics Pink Sheet Highlights
| CEO | Mark Scharmann |
| Business Concentration | Shell Companies, Financial Services (View all Sectors) |
Bioethics [BOTH] is a Pink Sheet which is traded between brokers over the counter. The company currently falls under 'Nano-Cap' category with a current market capitalization of 295.15 K. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Bioethics's market, we take the total number of its shares issued and multiply it by Bioethics's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Bioethics conducts business under Financial Services sector and is part of Shell Companies industry. The entity has 1.14 M outstanding shares.
Bioethics currently holds about 554 in cash with (27.48 K) of positive cash flow from operations.
Check Bioethics Probability Of Bankruptcy
Ownership AllocationBioethics shows majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 88.53 percent of Bioethics outstanding shares that are owned by insiders signifies that they have been buying or selling the stock in recent months in anticipation of some upcoming event.
Check Bioethics Ownership Details
Bioethics Risk Profiles
| Mean Deviation | 2.97 | |||
| Standard Deviation | 12.26 | |||
| Variance | 150.28 | |||
| Risk Adjusted Performance | (0.08) |
Bioethics Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Bioethics without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run My Watchlist Analysis Now
My Watchlist AnalysisAnalyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |
| All Next | Launch Module |
Other Information on Investing in Bioethics Pink Sheet
Bioethics financial ratios help investors to determine whether Bioethics Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Bioethics with respect to the benefits of owning Bioethics security.